The therapeutic benefit to patients receiving mesenchymal stromal cell (MSC) therapy is not because the injected cells remain viable, but because of cell death, researchers at the Monash Biomedicine Discovery Institute (BDI) ...
Nov 11, 2021
0
29
Cardiac arrest survivors who are more mindful, or aware of the present in a nonjudgmental way, reported fewer symptoms of depression, anxiety and post-traumatic stress disorder than survivors who are less mindful, according ...
Nov 08, 2021
0
11
Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure. ...
Oct 28, 2021
0
36
Reactive oxygen species (ROS) can act as signal carriers during the evolution of malignant tumors. At the appropriate concentration, ROS mediate signal transduction and cell growth. However, ROS are a double-edged sword, ...
Oct 20, 2021
0
2
Cancer therapies have seen great development over the decades. Radiotherapies and chemotherapies have saved countless lives, but the latest arsenal, adoptive cell therapies (ACT), has stirred most excitement. In ACT, cells ...
Oct 18, 2021
0
4
The immune system protects the body from cancer. To protect healthy body cells from its own immune system, they have developed a protective shield: the protein CD47 is a so called "don't eat me" signal, which tells the immune ...
Oct 12, 2021
0
4
Although hormone therapy (HT) remains the most effective treatment for menopause symptoms, some women have hesitated to use it because of concerns about various adverse health effects. A new study, however, is reducing some ...
Oct 06, 2021
0
14
Researchers from the University of Basel have developed an augmented reality app for smartphones in order to help people reduce their fear of spiders. The app has already shown itself to be effective in a clinical trial, ...
Sep 20, 2021
0
8
The first randomised phase III clinical trial in stage II melanoma has shown a 35% reduction in the risk of recurrence with adjuvant pembrolizumab compared with placebo. The late breaking results of the KEYNOTE-716 trial are presented ...
Sep 20, 2021
0
4
The integration of behavioral medicine and perioperative care is gaining traction, helped by improved technology that enables online consults and education as well as by better models of integration.
Sep 16, 2021
0
3
